Equities research analysts predict that UnitedHealth Group Inc (NYSE:UNH) will post sales of $56.13 billion for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for UnitedHealth Group’s earnings, with the highest sales estimate coming in at $56.51 billion and the lowest estimate coming in at $55.82 billion. UnitedHealth Group posted sales of $50.32 billion during the same quarter last year, which would indicate a positive year over year growth rate of 11.5%. The firm is expected to report its next quarterly earnings report before the market opens on Tuesday, October 16th.
On average, analysts expect that UnitedHealth Group will report full year sales of $224.86 billion for the current fiscal year, with estimates ranging from $224.03 billion to $225.98 billion. For the next year, analysts forecast that the firm will post sales of $243.27 billion, with estimates ranging from $238.87 billion to $245.74 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for UnitedHealth Group.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 17th. The healthcare conglomerate reported $3.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.04 by $0.10. The firm had revenue of $56.09 billion during the quarter, compared to analyst estimates of $56.10 billion. UnitedHealth Group had a return on equity of 22.79% and a net margin of 5.55%. UnitedHealth Group’s quarterly revenue was up 12.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.46 earnings per share.
In other news, Director William C. Ballard, Jr. sold 10,000 shares of the company’s stock in a transaction on Wednesday, August 8th. The stock was sold at an average price of $258.83, for a total transaction of $2,588,300.00. Following the transaction, the director now directly owns 77,172 shares of the company’s stock, valued at $19,974,428.76. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Kenneth Irwin Shine sold 177 shares of the company’s stock in a transaction on Wednesday, July 18th. The stock was sold at an average price of $255.72, for a total value of $45,262.44. Following the transaction, the director now directly owns 29,053 shares in the company, valued at $7,429,433.16. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 94,745 shares of company stock worth $24,995,290. Insiders own 0.87% of the company’s stock.
Several hedge funds have recently modified their holdings of the company. Welch Group LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $106,000. Blue Chip Partners Inc. acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $107,000. Northwest Wealth Management LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $117,000. Fort L.P. acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $119,000. Finally, Bruderman Asset Management LLC acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at $134,000. 85.35% of the stock is currently owned by institutional investors and hedge funds.
Shares of NYSE UNH traded up $0.88 during trading hours on Tuesday, reaching $269.20. The stock had a trading volume of 2,045,658 shares, compared to its average volume of 3,071,192. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.75 and a current ratio of 0.75. The firm has a market capitalization of $256.06 billion, a price-to-earnings ratio of 26.73, a PEG ratio of 1.58 and a beta of 0.73. UnitedHealth Group has a 52-week low of $186.00 and a 52-week high of $272.07.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 18th. Stockholders of record on Friday, September 7th were given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.34%. The ex-dividend date of this dividend was Thursday, September 6th. UnitedHealth Group’s payout ratio is presently 35.75%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: What are the risks of holding treasury bonds?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.